No regrets: Young adult patients in psychiatry report positive reactions to biobank participation

被引:16
|
作者
Cunningham, Janet L. [1 ]
Zanzi, Manuel [1 ]
Willebrand, Mimmie [1 ]
Ekselius, Lisa [1 ]
Ramklint, Mia [1 ]
机构
[1] Univ Uppsala Hosp, Dept Neurosci, Psychiat, Entrance 10,Floor 3B, S-75185 Uppsala, Sweden
关键词
Biobanking; Disability; Ethics; General psychiatry; Voluntariness; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; RATING-SCALE; RELIABILITY; VALIDITY; TRAUMA; INSTRUMENT; DEPRESSION; DISORDERS; CHILDREN; MINI;
D O I
10.1186/s12888-017-1199-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Research in vulnerable individuals must insure voluntariness and minimize negative reactions caused by participation. This study aimed to describe consent and completion rate in young psychiatric patients in relation to study components, degree of disability and to compare response to research participation in patients and controls. Methods: Between 2012 and 2015, 463 patients with psychiatric disorders between the ages of 18-25 from the Dept. of General Psychiatry at Uppsala University Hospital and 105 controls were recruited to donate data and samples to a biobank. Consent and completion in relation to questionnaires, biological sampling of blood, saliva or feces, were monitored. Both groups were also asked about their perceived disability and how research participation affected them. Results: Most patients who participated consented to and completed questionnaires and blood sampling. The majority also consented to saliva sampling, while less than half consented to collect feces. Of those who gave consent to saliva and feces only half completed the sampling. Both patients and controls reported high voluntariness and were positive to research participation. Within the patient group, those with greater perceived disability reported greater distress while participating in research, but there was no difference in consent or completion rates or level of regret. Conclusions: With the described information procedures, psychiatric patients, regardless of perceived disability, reported high voluntariness and did not regret participation in biobanking. Compared to questionnaires and blood sampling, given consent was reduced for feces and completion was lower for both saliva and feces sampling.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Budd-Chiari syndrome in very young adult patients with polycythemia vera: report of case series with good outcome with direct thrombin inhibitor treatment
    Goldstein, Gal
    Maor, Jacob
    Kleinbaum, Yeruham
    Palumbo, Michal
    Sidi, Yehezkel
    Salomon, Ophira
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (08) : 848 - 853
  • [42] Clinical next generation sequencing of adolescents and young adult (AYA) patients with cancer reveals aggressive biology: A preliminary report from a major cancer center
    Bupathi, Manojkumar
    Hong, David S.
    Anderson, Pete M.
    Subbiah, Vivek
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Young adult Swedish patients with autoimmune Addison's disease report difficulties with executive functions in daily life despite overall good cognitive performance
    van't Westeinde, Annelies
    Strom, Sara
    Hirvikoski, Tatja
    Dahlqvist, Per
    Wahlberg, Jeanette
    Gezelius, Anton
    Kampe, Olle
    Bensing, Sophie
    Lajic, Svetlana
    PSYCHONEUROENDOCRINOLOGY, 2022, 140
  • [44] PSYCHOSOCIAL-ASPECTS OF YOUNG-ADULT GROWTH-HORMONE DEFICIENT PATIENTS PREVIOUSLY TREATED WITH HUMAN GROWTH-HORMONE - A PRELIMINARY-REPORT
    LARON, Z
    ARAN, O
    NOFAR, E
    BEITHALACHMI, N
    PERTZELAN, A
    GALATZER, A
    ACTA PAEDIATRICA SCANDINAVICA, 1986, : 80 - 82
  • [45] Phase 1 trial of brentuximab vedotin in combination with gemcitabine for pediatric and young adult patients with relapsed or refractory Hodgkin lymphoma, a Children's Oncology Group report
    Cole, Peter D.
    Metzger, Monika
    Drachtman, Richard A.
    Horton, Terzah M.
    Liu, Xiaowei
    Ahern, Charlotte H.
    Minard, Charles
    Fox, Elizabeth
    Blaney, Susan
    Weigel, Brenda
    Kelly, Kara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Factors associated with adherence to antiretroviral therapy among HIV-positive adolescents and young adult patients attending HIV care and treatment clinic at Bombo Hospital in Tanga region-Tanzania
    Kamote, Sophia
    Tesha, Novatus Apolinary
    Sunguya, Bruno F.
    PLOS ONE, 2025, 20 (01):
  • [47] Phase 2 trial of brentuximab vedotin and gemcitabine for pediatric and young adult patients with relapsed or refractory Hodgkin lymphoma (HL): A Children's Oncology Group (COG) report.
    Cole, Peter D.
    McCarten, Kathleen
    Metzger, Monika
    Drachtman, Richard A.
    Horton, Terzah M.
    Pei, Qinglin
    Bush, Rizvan
    Blaney, Susan
    Weigel, Brenda
    Kelly, Kara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Daver, Naval
    Thomas, Deborah
    Ravandi, Farhad
    Cortes, Jorge
    Garris, Rebecca
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Kadia, Tapan
    Rytting, Michael
    Konopleva, Marina
    Kantarjian, Hagop
    O'Brien, Susan
    HAEMATOLOGICA, 2015, 100 (05) : 653 - 661
  • [49] Time to development of adverse drug reactions and associated factors among adult HIV positive patients on antiretroviral treatment in Bahir Dar City, Northwest Ethiopia (vol 12, e0189322, 2017)
    Kindie, E.
    Anteneh, Alamrew Z.
    Worku, E.
    PLOS ONE, 2019, 14 (08):
  • [50] CASSIOPEIA: A phase 2 study evaluating efficacy and safety of tisagenlecleucel in first-line therapy for high-risk pediatric and young adult patients with B-ALL who are MRD positive at the EOC
    Maude, Shannon
    Stephen, Hunger
    Buechner, Jochen
    Grupp, Stephen
    Rives, Susana
    Baruchel, Andre
    Levine, John
    Krueger, Joerg
    Laetsch, Theodore
    Ifversen, Marianne
    Zia, Aiesha
    Davis, Jaclyn
    Bleickardt, Eric
    Loh, Mignon
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7